Advertisement
Home »

Early intervention in myelofibrosis and impact on outcomes: A pooled analysis of the COMFORT-I and COMFORT-II studies.

Feb 27, 2023

ABOUT THE EXPERTS

  • Srdan Verstovsek

    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

    Jean-Jacques Kiladjian

    Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, INSERM, Paris, France.

    Alessandro M Vannucchi

    Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy.

    Ruben A Mesa

    Mays Cancer Institute, UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas, USA.

    Peg Squier

    Incyte Corporation, Wilmington, Delaware, USA.

    J E Hamer-Maansson

    Incyte Corporation, Wilmington, Delaware, USA.

    Claire Harrison

    Guy’s Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement